Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues.

× No keyword cloud information.

11 in total

1. Cardiac Causes of Stroke.

Authors:
Journal: Curr Treat Options Neurol Date: 2000-07 Impact factor: 3.598

Review 2. Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide.

Authors: James E Stahl
Journal: Pharmacoeconomics Date: 2008 Impact factor: 4.981

3. Combined survival analysis of cardiac patients by a Cox PH model and a Markov chain.

Authors: Michal Shauly; Gad Rabinowitz; Harel Gilutz; Yisrael Parmet
Journal: Lifetime Data Anal Date: 2011-07-07 Impact factor: 1.588

4. Cost effectiveness of fondaparinux in non-ST-elevation acute coronary syndrome.

Authors: Jaime Latour-Perez; Eva de-Miguel-Balsa
Journal: Pharmacoeconomics Date: 2009 Impact factor: 4.981

5. Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients.

Authors: Andrew Frazer; James Rowland; Alison Mudge; Michael Barras; Jennifer Martin; Peter Donovan
Journal: Eur J Clin Pharmacol Date: 2019-09-11 Impact factor: 2.953

6. Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness.

Authors: John Wright; John Bibby; Joe Eastham; Stephen Harrison; Maureen McGeorge; Chris Patterson; Nick Price; Daphne Russell; Ian Russell; Neil Small; Matt Walsh; John Young
Journal: Qual Saf Health Care Date: 2007-02

Review 7. Cost effectiveness of therapies for atrial fibrillation. A review.

Authors: M P Teng; L E Catherwood; D P Melby
Journal: Pharmacoeconomics Date: 2000-10 Impact factor: 4.981

8. Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation.

Authors: Mark L Wess; Daniel P Schauer; Joseph A Johnston; Charles J Moomaw; David E Brewer; E Francis Cook; Mark H Eckman
Journal: J Gen Intern Med Date: 2008-04 Impact factor: 5.128

Review 9. Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants.

Authors: Charalampos Kasmeridis; Stavros Apostolakis; Lars Ehlers; Lars H Rasmussen; Giuseppe Boriani; Gregory Y H Lip
Journal: Pharmacoeconomics Date: 2013-11 Impact factor: 4.981

10. Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment.

Authors: Peter Ghijben; Emily Lancsar; Silva Zavarsek
Journal: Pharmacoeconomics Date: 2014-11 Impact factor: 4.981